内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Sundaram Preethi. Director active across 1 company, notably Catalyst Pharmaceuticals, INC.. In total, 15 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €54k. Activity tracked since 15 September 2022. The latest transaction was filed on 15 July 2026 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Sundaram Preethi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
54,804 股@ US$31.50Common Stock, par value $0.001 per shareSEC:0001161697-26-000182:0
6,667 股Common Stock, par value $0.001 per shareSEC:0001161697-25-000495:0
2,369 股Common Stock, par value $0.001 per shareSEC:0001161697-25-000495:1
6,855 股Common Stock, par value $0.001 per shareSEC:0001161697-25-000449:0
5,603 股Common Stock, par value $0.001 per shareSEC:0001161697-25-000422:0
2,324 股@ US$26.4111.7% 占其流量Common Stock, par value $0.001 per shareSEC:0001161697-25-000189:0
16,667 股Common Stock, par value $0.001 per shareSEC:0001161697-25-000072:0
6,667 股Common Stock, par value $0.001 per shareSEC:0001161697-24-000544:0
2,345 股Common Stock, par value $0.001 per shareSEC:0001161697-24-000544:1
6,855 股Common Stock, par value $0.001 per shareSEC:0001161697-24-000507:0
16,667 股Common Stock, par value $0.001 per shareSEC:0001161697-24-000105:0
6,666 股Common Stock, par value $0.001 per shareSEC:0001161697-23-000652:0
16,666 股Common Stock, par value $0.001 per shareSEC:0001161697-23-000134:0
56,786 股@ US$5.4975.3% 占其流量Common stock, par value $0.001 per shareSEC:0001161697-22-000550:0
18,214 股@ US$5.4924.7% 占其流量Common stock, par value $0.001 per shareSEC:0001161697-22-000469:0
About Sundaram Preethi
Sundaram Preethi is a declarant linked to Catalyst Pharmaceuticals, INC. on XNAS, where the listed role is Chief Strategy Officer. There are 11 filings in total, and the sampled recent filings cover the period from 2022-09-16 to 2025-12-30, with the modal transaction nature listed as option exercise.